TwinBeech Capital’s Edgewise Therapeutics EWTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.05M Buy
+25,800
New +$1.1M 0.24% 125
2025
Q3
– Sell
-78,280
Closed -$1.03M – 643
2025
Q2
$1.03M Sell
78,280
-22,546
-22% -$325K 0.02% 411
2025
Q1
$2.22M Buy
+100,826
New +$2.65M 0.04% 375

Other funds holding EWTX

TwinBeech Capital's EWTX Position: Q3 2026 in Review

TwinBeech Capital opened a new position in Edgewise Therapeutics (EWTX) in Q3 2026: 25,800 shares worth $1.05M. The stake represents 0.24% of the portfolio and ranks #125 among its holdings. This is a return to the name: TwinBeech Capital previously reported a position in EWTX as recently as Q2 2025.

TwinBeech Capital first reported a position in EWTX in Q1 2025 and has held it in 3 quarters since. The position peaked at $2.22M in Q1 2025. 253 funds tracked by Wall St. Rank hold EWTX as of Q3 2026.

  • TwinBeech Capital held 25,800 shares of Edgewise Therapeutics worth $1.05M as of Q3 2026.
  • Edgewise Therapeutics was a new TwinBeech Capital position in Q3 2026.
  • Edgewise Therapeutics made up 0.24% of TwinBeech Capital's portfolio in Q3 2026, its #125 holding.
  • TwinBeech Capital first reported a position in Edgewise Therapeutics in Q1 2025 and has held it in 3 quarters since.
  • TwinBeech Capital's Edgewise Therapeutics position peaked at $2.22M in Q1 2025.
  • 253 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q3 2026.

Based on TwinBeech Capital's 13F filing for Q3 2026, filed 16 Nov 2026.